A new analysis has revealed detailed information about genetic variation in brain cells that could open new avenues for the targeted treatment of diseases such as schizophrenia and Alzheimer’s disease.
European AI startup raises $24M for protein design software service
A European startup is betting that drug companies big and small will look to outsource artificial intelligence expertise that can help design new protein-based medicines.
November 28, 2023